Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Axcel and Accru Partners in connection with the acquisition of Sporrong & Eriksson Revisionsbyrå AB
Mandate

Vinge advises Axcel and Accru Partners in connection with the acquisition of Sporrong & Eriksson Revisionsbyrå AB

February 12, 2025 M&A Employment and Benefits Banking and Finance Commercial Agreements IT, Telecommunications and Outsourcing Intellectual Property Data protection and processing of personal data Real Estate and Construction Financial Regulatory

Vinge has advised Axcel VII and Accru Partners in connection with the acquisition of Sporrong & Eriksson Revisionsbyrå AB.

Sporrong & Eriksson Revisionsbyrå AB is an entrepreneur-led, local business with expertise in accounting, audit, tax, acquisition and advisory services. After the acquisition, Accru Partners consists of 28 independent firms within the aforementioned business areas.

Vinge’s team consisted of Christina Kokko, Egil Svensson, Michella Lina Said and Chris Bastholm (M&A), Narin Melazade and Simon Söderholm (Employment), Sofia Haggren (Banking and Finance), Mario Saad (Commercial Agreements), Elis Allmark (IT), Rebecka Målquist (Intellectual Property), Nicklas Thorgerzon (GDPR), Madelene Andersson (Real Property), Jonna Bondemark (Regulatory), Gulestan Ali and Jonna Fransson (Compliance) and Jessica Öijer (Transaction Support Coordinator).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025